Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

205.78 -1.54 (-0.74%)

Official Closing Price Updated: 4:00 PM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock ↗

April 17, 2025

Via Benzinga

Topics Retirement

4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market ↗

April 17, 2025

Via The Motley Fool

Topics Earnings Government World Trade

This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row ↗

April 17, 2025

Via The Motley Fool

Topics Bonds

Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ ↗

April 17, 2025

Johnson & Johnson and Albertsons Companies' stock have provided a pleasant hedge against market volatility, with the S&P 500 and Nasdaq remaining near correction territory.

Via Talk Markets

Topics Stocks Stocks / Equities

Healthcare Sector Update: MEDtech And Diagnostics ↗

April 16, 2025

Amidst the tariff chaos, we may get clues from one of the most defensive sectors of the market-healthcare stocks.

Via Talk Markets

Topics ETFs Stocks / Equities World Trade

Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

April 16, 2025

From Johnson & Johnson

Via Business Wire

Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction ↗

April 16, 2025

Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating...

Via Benzinga

Topics Government

How Is The Market Feeling About Johnson & Johnson? ↗

April 16, 2025

Via Benzinga

Johnson & Johnson's Q1 Results, FY Guidance Highlight The 'Power Of The Pharma Portfolio' ↗

April 16, 2025

Johnson & Johnson (JNJ) reported upbeat Q1 results amid an exciting earnings season, with analysts noting impressive sales and guidance from the pharma giant.

Via Benzinga

Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy?

April 16, 2025

Johnson & Johnson had more good than bad; investors should look at the entire report in context before deciding if JNJ stock is a good fit for their portfolios

Via MarketBeat

Topics Government Intellectual Property World Trade

Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit ↗

April 15, 2025

Johnson & Johnson raised its 2025 sales outlook and dividend, while Q1 results topped expectations driven by strong cancer drug performance.

Via Benzinga

2 Under-the-Radar Consumer Staples Stocks With Big Dividends

April 15, 2025

Edgewell and Kenvue are under-the-radar consumer staples stocks poised to gain as the U.S. dollar declines. Learn why they may boost your income portfolio.

Via MarketBeat

Topics ETFs Intellectual Property World Trade

Johnson & Johnson Skids Despite First-Quarter Beat, Sales Guidance Hike ↗

April 15, 2025

Johnson & Johnson stock fell alongside the broader market, despite beating first-quarter calls and hiking its sales outlook.

Via Investor's Business Daily

Topics Government Stocks

Johnson & Johnson’s Q1 Earnings Beat Estimates, 2025 Guidance Revised To Account For Intra-Cellular Therapies Acquisition: Retail’s Positive ↗

April 15, 2025

The company said the updated guidance includes costs estimated to be incurred as part of Trump’s tariffs on certain imports into the U.S.

Via Stocktwits

Topics Earnings Government World Trade

Johnson & Johnson Reports Strong Q1 Performance ↗

April 15, 2025

Johnson & Johnson's first-quarter results surpassed expectations with notable growth in sales and earnings.

Via Talk Markets

Topics Stocks / Equities

Johnson & Johnson’s (NYSE:JNJ) Q1 Sales Top Estimates, Full-Year Sales Guidance is Optimistic

April 15, 2025

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.4% year on year to $21.89 billion. The company’s...

Via StockStory

Topics Intellectual Property

Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%

April 15, 2025

From Johnson & Johnson

Via Business Wire

Johnson & Johnson Reports Q1 2025 Results

April 15, 2025

From Johnson & Johnson

Via Business Wire

US Stock Futures Waver After Two-Day Rally: Trump's Tariff Moves Could End A 3-Year 'Rolling Recession,' Says Expert ↗

April 15, 2025

U.S. stock futures were volatile on Tuesday following a two-day advance. Futures of major benchmark indices were mixed in premarket.

Via Benzinga

Topics Government

Citigroup, Bank Of America And 3 Stocks To Watch Heading Into Tuesday ↗

April 15, 2025

Via Benzinga

Earnings Scheduled For April 15, 2025 ↗

April 15, 2025

Via Benzinga

Johnson & Johnson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

April 15, 2025

Via Benzinga

US Stock Futures Slip As Investors Brace Themselves For Netflix, AmEx Earnings This Week — Nikkei Up On Strong Sentiment ↗

April 14, 2025

After two days of back-to-back gains in the spot market, U.S. stock futures had a choppy session Monday night as investors await several prominent companies' earnings reports this week.

Via Benzinga

34-Year-Old Making $3,400 a Month in Dividends Shares His Top 7 Stocks — 'Be Lucky and Save Relentlessly' ↗

April 14, 2025

Via Benzinga

Johnson & Johnson (JNJ) Reports Earnings Tomorrow: What To Expect

April 14, 2025

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) will be reporting results tomorrow before market open. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Examining the Future: Johnson & Johnson's Earnings Outlook ↗

April 14, 2025

Via Benzinga

Are Tariff Worries Affecting The Earnings Outlook? ↗

April 11, 2025

There are valid reasons for the market to remain focused on the tariffs issue since so much is happening in the broader economy.

Via Talk Markets

Topics Stocks / Equities World Trade

Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties ↗

April 11, 2025

Novartis commits $23 billion to expand U.S. manufacturing and R&D with 10 new facilities, aiming to produce all key U.S. medicines domestically and add thousands of jobs.

Via Benzinga

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies ↗

April 11, 2025

Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.

Via Benzinga

Topics Government World Trade

2 Top Dividend Stocks to Buy Right Now ↗

April 11, 2025

Via The Motley Fool

Topics Artificial Intelligence Government Lawsuit

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Johnson & Johnson (NY:JNJ)

All News about Johnson & Johnson

Starting at $3.75/week.

Subscribe Today